Form 8-K · Current Report · Filed 2025-10-21
Hologic Announces Merger Agreement with Blackstone and TPG
Hologic, Inc. announced on October 21, 2025, that it has entered into a definitive Agreement and Plan of Merger with funds managed by Blackstone and TPG. Under the terms of the agreement, Blackstone and TPG will acquire all outstanding Hologic shares for $76 per share in cash plus a contingent value right (CVR) to receive up to $3 per share, totaling up to $79 per share. The transaction, which includes minority investments from ADIA and GIC, is expected to close in the first half of 2026 and is subject to stockholder approval and regulatory conditions. Hologic has also granted cash retention awards to certain executive officers in connection with the merger. The merger agreement and a related press release are filed as exhibits to this 8-K report.
- Filer
- Hologic Inc. HOLX · NASDAQ
- Filed
- Accession
- 0001193125-25-244423
- CIK
- 0000859737
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Entry into a Material Definitive Agreement
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Other Events
Financial Statements and Exhibits
Market reaction
Close before filing
$71.87
Next session
+2.9%
Since filing
+5.8%
Latest close
$76.01
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from HOLX reporting the same item, with the next session's move:
About Hologic Inc.
Hologic Inc. is a leading global medical technology company focused on improving women's health and well-being. Its primary function is to develop, manufacture, and supply diagnostic products, medical imaging systems, and surgical products, which play crucial roles in the prevention and treatment of diseases. Hologic's key sectors include breast health, diagnostics, gynecological surgical, and skeletal health solutions. It is renowned for innovative technologies such as 3D mammography or tomosynthesis, which are significant advancements in breast cancer detection. With a commitment to enhancing healthcare quality and efficiency, Hologic operates across a diverse range of healthcare settings, from hospitals and clinics to laboratories and research facilities. Headquartered in Marlborough, Massachusetts, Hologic has established itself as a pivotal player in women's health diagnostics, contributing to its substantial market presence and influence in the global healthcare sector.
Never miss another HOLX filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.